Physician profile
Jonathan Paul Giannone
NPI 1629226881
$2,844.17
in general payments reported to CMS, 2019-2025
16 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $81.14 · 2021: $319 · 2022: $335 · 2023: $512 · 2024: $294 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $990.83 | 2019-2024 | Da Vinci Surgical System |
| Novo Nordisk INC | $582.63 | 2019-2025 | Wegovy, Saxenda, Rybelsus |
| Medtronic, INC. | $441.25 | 2022-2025 | Ligasure, Signia |
| Currax Pharmaceuticals LLC | $185.89 | 2020-2025 | Contrave |
| Allergan, INC. | $171.34 | 2021-2022 | |
| Dilon Technologies, INC. | $146.60 | 2024 | Hemoblast Bellows |
| Lilly USA, LLC | $64.30 | 2025 | Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $51.68 | 2022-2023 | Gattex |
| Intra-Sana Laboratories | $47.21 | 2021-2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| W. L. Gore & Associates, INC. | $37.67 | 2019-2025 | Gore Enform Preperitoneal Biomaterial |
| Eisai INC. | $35.43 | 2019 | |
| Heron Therapeutics, INC. | $26.87 | 2022 | |
| Olympus America INC. | $20.59 | 2019 | |
| Davol INC. | $14.37 | 2023 | Phasix Mesh |
| Nalpropion Pharmaceuticals LLC | $13.78 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Giannone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.